113
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, structure, and bioevaluation of 2,5-bis(arylmethenyl)cyclopentanones

, , , , , , , , & show all
Pages 957-965 | Received 08 Jan 2008, Accepted 30 Apr 2008, Published online: 11 Nov 2008
 

Abstract

Curcumin is an excellent lead compound with a variety of bioactivity. Recent articles reported that curcumin's instability and low bioavailability in vivo are mainly due to its easily decomposable β-diketone moiety. With the aim of bioactive curcumin analogs with better pharmacokinetic property, we present here 11 bis(arylmethenyl)cyclopentanones similar to curcumin and without β-diketone moiety by reacting relevant arylaldehydes and cyclopentanones. The analogs were structurally determined by 1HNMR and MS spectra, and the crystal structure of 6 was analyzed by X-ray diffraction. Their antibacterial activities in vitro against seven Gram-positive and Gram-negative bacteria were tested, and their inhibition of TNF-α and IL-6 secretion in LPS-induced mouse macrophages was investigated using enzyme-linked immunosorbent assay. It was observed that several derivatives displayed higher activity when compared with curcumin, and most of the analogs exhibited activities against the ampicillin-resistant Gram-negative Enterobacter cloacae.

Acknowledgements

This work was supported by the general grant of Zhejiang administration of Chinese Traditional Medicine (2007CA080 and 2007CA079), Wenzhou key research project (S2005B001), and research project of Wenzhou Medical College (89007046), and also by the Zhejiang Department of Education science grant (20070992).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.